You have 9 free searches left this month | for more free features.

Hemangioendothelioma

Showing 1 - 25 of 29

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma Trial in Chengdu (Tacrolimus ointment)

Recruiting
  • Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
  • Tacrolimus ointment
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Jan 15, 2023

Hemangioma, Kaposiform Hemangioendothelioma Trial in Shanghai (Sirolimus(0.8mg/m2), Sirolimus(0.7mg/m2))

Completed
  • Hemangioma
  • Kaposiform Hemangioendothelioma
  • Shanghai, China
    Children's Hospital of Fudan University
Jan 27, 2023

Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome Trial in Shanghai (Sirolimus)

Recruiting
  • Kaposiform Hemangioendothelioma
  • Kasabach-Merritt Syndrome
  • Shanghai, Shanghai, China
    Children's Hospital of Fudan University
Oct 21, 2022

Hemangioendothelioma Trial in Chengdu (Sirolimus)

Recruiting
  • Hemangioendothelioma
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
May 1, 2022

Kaposiform Hemangioendothelioma Trial in Chengdu (Sirolimus)

Recruiting
  • Kaposiform Hemangioendothelioma
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Apr 6, 2022

Angiosarcoma, Epithelioid Hemangioendothelioma Trial in Boston (Eribulin)

Recruiting
  • Angiosarcoma
  • Epithelioid Hemangioendothelioma
  • Boston, Massachusetts
  • +1 more
Feb 14, 2022

Sirolimus on Immunizations During Treatment of Kaposiform

Recruiting
  • Kaposiform Hemangioendothelioma
    • Shanghai, Shanghai, China
      Children's Hospital of Fudan University
    Apr 22, 2022

    Kaposiform Hemangioendothelioma, Tufted Angioma, Superficial Vascular Anomalies Trial in Shanghai (Percutaneous sirolimus, Oral

    Recruiting
    • Kaposiform Hemangioendothelioma
    • +3 more
    • Percutaneous sirolimus
    • Oral sirolimus
    • Shanghai, China
      Children's Hospital of Fudan University
    Jan 9, 2023

    Solid Tumors, Adult, Solid Tumor, Mesothelioma (MPM) Trial in United States (IK-930)

    Recruiting
    • Solid Tumors, Adult
    • +7 more
    • Boston, Massachusetts
    • +6 more
    Jan 24, 2023

    Lymphatic Malformation, Generalized Lymphatic Anomaly (GLA), Central Conducting Lymphatic Anomaly Trial in Boston

    Recruiting
    • Lymphatic Malformation
    • +9 more
      • Boston, Massachusetts
        Boston Children's Hospital
      Sep 8, 2022

      Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma Trial in France (Patient with Soft Tissue Sarcoma)

      Recruiting
      • Soft Tissue Sarcoma
      • +9 more
      • Patient with Soft Tissue Sarcoma
      • Besancon, France
      • +13 more
      Oct 11, 2022

      Deep Learning Magnetic Resonance Imaging Radiomics for

      Recruiting
      • Hepatoblastoma
      • Hepatic Hemangioendothelioma
      • Radiomic Algorithm
      • Chendu, Sichuan, China
        West China Hospital, Sichuan University
      Dec 22, 2021

      Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma Trial in Bordeaux (Trabectedin)

      Recruiting
      • Soft Tissue Sarcoma Adult
      • +6 more
      • Bordeaux, France
        Institut Bergonie
      Feb 1, 2022

      PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and

      Completed
      • Hepatoblastoma
      • Hepatic Hemangioendothelioma
      • PIVKA-II
      • Shanghai, Shanghai, China
        Shanghai Children's Medical Center, Shanghai Jiaotong University
      Jul 16, 2021

      Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

      Completed
      • Adult Alveolar Soft Part Sarcoma
      • +18 more
      • Portland, Oregon
      • +1 more
      Sep 23, 2021

      Hemangioendothelioma of Liver Trial in Shanghai (Sirolimus Oral Product, propranolol)

      Not yet recruiting
      • Hemangioendothelioma of Liver
      • Shanghai, Shanghai, China
        Shanghai Children's Medical Center Shanghai Jiaotong University
      May 23, 2020

      Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP) Trial in Shanghai (prednison and Sirolimus,

      Not yet recruiting
      • Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
      • Shanghai, Shanghai, China
        Shanghai Children's Medical Center Shanghai Jiaotong University
      Jun 5, 2020

      Congenital Hemangioma, Hemangioendothelioma, Angiosarcoma Trial in Gurgaon, Vellore (Lipiodol® Ultra Fluid with surgical glues)

      Unknown status
      • Congenital Hemangioma
      • +3 more
      • Lipiodol® Ultra Fluid with surgical glues
      • Gurgaon, Haryana, India
      • +1 more
      Feb 18, 2020

      Soft Tissue Sarcoma Trial in Shanghai (Fruquintinib)

      Recruiting
      • Soft Tissue Sarcoma
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Mar 1, 2022

      Advanced Sarcoma Trial in United States (Lenvatinib, Pembrolizumab)

      Recruiting
      • Advanced Sarcoma
      • Basking Ridge, New Jersey
      • +6 more
      Jul 8, 2022

      Hemangioma Trial in Indianapolis, Columbus (PediaBerry)

      Recruiting
      • Hemangioma
      • Indianapolis, Indiana
      • +1 more
      Aug 13, 2021

      Advanced and/or Metastatic Sarcoma Trial in Houston (Durvalumab, Tremelimumab)

      Active, not recruiting
      • Advanced and/or Metastatic Sarcoma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Dec 7, 2022

      Vascular Anomalies Trial in Guangzhou (Treatment with oral rapmycin)

      Recruiting
      • Vascular Anomalies
      • Treatment with oral rapmycin
      • Guangzhou, Guangdong, China
        Zhujiang Hospital
      Nov 9, 2021

      Perihilar Cholangiocarcinoma, Klatskin Tumor, Bile Duct Cancer Trial in Oslo (Liver transplant)

      Recruiting
      • Perihilar Cholangiocarcinoma
      • +2 more
      • Liver transplant
      • Oslo, Norway
        Oslo university hospital
      Aug 5, 2021